Glyconics Secures £1.5m Investment

22nd November 2021

Glyconics, which is part of the Deepbridge Life Sciences EIS portfolio, has secured £1.5 million in an Enterprise Investment Scheme (EIS) funding round ahead of a series A round next year. 

VoxSmart Opens APAC Office As Part Of Global Expansion

25th November 2021

VoxSmart Ltd, which is part of Deepbridge Technology Growth EIS portfolio, has recently cemented its Asia-Pacific (APAC) presence with the opening of a brand-new office in Queenstown, New Zealand, further building on it's global growth over the previous year.

Deepbridge Sponsors The Hardman & Co TES White Paper

26th November 2021

Deepbridge are pleased to announce that we have sponsored the Hardman & Co’s TES White Paper, which investigates the effect of adding venture capital to equity/bond portfolios for investors. The paper also shows that venture capital makes a compelling addition, significantly improving investors’ risk/return profiles.